Leading Element Driving Change in the Drug Discovery Outsourcing Market in 2025: Chronic Diseases Propel Growth Of The Drug Discovery Outsourcing Market Driver

What Is the Estimated Market Size and Growth Rate for the Drug Discovery Outsourcing Market?
In recent years, the market size for outsourcing drug discovery has shown a robust growth. The figures are set to increase from $3.92 billion in 2024 to $4.24 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.1%. Factors such as increased complexity in drug discovery, the requirement for specialized skills, strict regulatory standards, the internationalization of clinical trials, and the surge in demand for personalized medicine and orphan drugs have contributed to the growth during the historical period.

The market size of drug discovery outsourcing is slated for robust expansion in the upcoming years, ballooning to a notable $5.72 billion by 2029 with a compound annual growth rate (CAGR) of 7.8%. This projected surge during the forecast period can be linked to a rise in research and development costs, patent terminations, growth in the biopharmaceutical industry, emphasis on core capabilities, as well as the urgency to minimize the time-to-market. The forecast period will also see formidable trends such as increasing integration of artificial intelligence, advances in technology, data analytics, specialized medicines, and strategic partnerships.

What Are the Forces Behind the Rapid Growth of the Drug Discovery Outsourcing Market?
The escalating occurrence of chronic illnesses is anticipated to boost the drug discovery outsourcing market's expansion. These are enduring health issues that continue over time, typically for years or even an entire lifetime. Numerous factors, such as aging population, lifestyle habits, urbanization, and environmental aspects, contribute to the rise of chronic diseases. Outsourcing in drug discovery fast-tracks the creation of chronic disease treatments by offering access to specialized skill sets and innovative technologies, thus lowering time and cost. For instance, the Australian Institute of Health and Welfare, an Australian government agency, reported in June 2024 that 61% of the population, approximately 15.4 million people, suffered from at least one long-term health issue, accounting for 90% of deaths in 2022. Anxiety impacted 1.3 million (16%) individuals between 0-24 years, and 1.6 million (22%) between 25-44 years. Back problems were noted among 1.5 million (23%) aged 45-64, while 1.3 million (32%) of those aged 65 and above reported deafness or hearing loss. Hence, the increasing occurrence of chronic diseases propels the growth of the drug discovery outsourcing market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19405&type=smp

Who Are the Dominant Companies Influencing Drug Discovery Outsourcing Market Trends?
Major companies operating in the drug discovery outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins SE, Charles River Laboratories, QIAGEN N.V., Curia Global Inc., EVOTEC, Pharmaron Beijing Co. Ltd., Genscript Biotech, WuXi AppTec, Pharmaceutical Product Development, LLC, Syngene International Limited, Jubilant Biosys, Dalton Pharma Services, Oncodesign Services, DiscoverX Corp., Domainex Ltd., Exscientia, TCG Lifesciences Pvt Ltd., GVK Biosciences Private Limited

How Is the Drug Discovery Outsourcing Market Evolving?
Established drug discovery outsourcing market players are shifting their focus towards new innovations like digital health solutions to cater to the demands of health professionals, regulators, and patients more effectively. Digital health solutions include various technological services such as telemedicine, mobile health applications, and wearable gadgets that upgrade health care provision, patient involvement, and health administration. For example, in November 2023, Evinova was launched by AstraZeneca PLC, a biopharmaceutical organization based in the UK. Evinova is a state-of-the-art health-tech venture committed to driving innovation in the life science sector and enhancing clinical trial delivery. Their goal is to improve health outcomes by providing globally-scaled digital products and services that have shown efficacy in AstraZeneca's clinical trials in over 40 countries. Evinova is aimed at refining the process of new drug development by enhancing clinical trial design and delivery, thereby saving both time and costs.

What Are the Different Segmentations in the Drug Discovery Outsourcing Market?
The drug discovery outsourcingmarket covered in this report is segmented -

1) By Service Type: Chemistry Services, Biological Services
2) By Workflow: Target Identification And Screening, Target Validation And Functional Informatics, Lead Identification And Candidate Optimization, Preclinical Development, Other Workflows
3) By Disease Model: In Vitro Models, Animal Models, Cellular Models, Other Disease Models
4) By Therapeutic Area: Cardiovascular, Central Nervous System (CNS), Gastrointestinal, Hematology, Respiratory System, Infectious Disease, Oncology, Immunology, Other Therapeutic Areas
5) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Other End Users

Subsegments:
1) By Chemistry Services: Custom Synthesis And Manufacturing, Medicinal Chemistry, Combinatorial Chemistry, Hit Identification And Lead Optimization, Process Chemistry And Scale-Up, Analytical Chemistry Services, Chemical Library Design And Screening, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Profiling
2) By Biological Services: Cell-Based Assays And Screening, Target Identification And Validation, In Vitro And In Vivo Testing, Biomarker Discovery And Development, Toxicology Studies, Genomics And Proteomics Services, Animal Models For Preclinical Development, Biological Safety And Efficacy Testing, Biopharmaceutical Development And Manufacturing.

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/drug-discovery-outsourcing-global-market-report

Which Region Is at the Forefront of the Drug Discovery Outsourcing Market?
North America was the largest region in the drug discovery outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Drug Discovery Outsourcing Global Market Report?

- Market Size Analysis: Analyze the Drug Discovery Outsourcing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Drug Discovery Outsourcing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Drug Discovery Outsourcing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Drug Discovery Outsourcing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19405

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.